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Abstract
Background: Personality disorder (PD) is associated with elevated suicide risk, but the level of risk in primary care
settings is unknown. We assessed whether PD among primary care patients is linked with a greater elevation in risk
as compared with other psychiatric diagnoses, and whether the association is modified by gender, age, type of PD,
and comorbid alcohol misuse.
Methods: Using data from the UK Clinical Practice Research Datalink, 2384 suicides were matched to 46,899 living
controls by gender, age, and registered practice. Prevalence of PD, other mental disorders, and alcohol misuse was
calculated for cases and controls separately and conditional logistic regression models were used to estimate
exposure odds ratios. We also fitted gender interaction terms and formally tested their significance, and estimated
gender age-specific effects.
Results: We found a 20-fold increase in suicide risk for patients with PD versus no recorded psychiatric disorder, and a
four-fold increase versus all other psychiatric illnesses combined. Borderline PD and PD with comorbid alcohol misuse
were associated with a 37- and 45-fold increased risk, respectively, compared with those with no psychiatric disorders.
Relative risks were higher for female than for male patients with PD. Significant risks associated with PD diagnosis were
identified across all age ranges, although the greatest elevations were in the younger age ranges, 16–39 years.
Conclusions: The large elevation in suicide risk among patients diagnosed with PD and comorbid alcohol misuse is a
particular concern. GPs have a potentially key role to play in intervening with patients diagnosed with PD, particularly
in the presence of comorbid alcohol misuse, which may help reduce suicide risk. This would mean working with
specialist care, agreed clinical pathways and availability of services for comorbidities such as alcohol misuse, as well as
opportunities for GPs to develop specific clinical skills.
Keywords: Personality disorder, Borderline personality disorder, Suicide, Alcohol misuse, Mental illness, Primary care,
General practitioners, Clinical Practice Research Datalink
Background
Over 5,000 suicides occur annually in England and Wales,
and suicide is the leading cause of death for 20–34 year
olds [1]. A diagnosis of personality disorder (PD), in par-
ticular borderline PD, has been found to be strongly linked
with elevated suicide risk [2–5]. For example, it has been
reported that PD was associated with a seven-fold increase
in suicide risk compared with those in the general popula-
tion with no mental illnesses [5]. In fact, persons with PD
are amongst those at greatest risk of suicide when com-
pared to patients from other psychiatric diagnostic groups
[6–8], while suicidal and self-injurious behaviour are seen
as defining features of borderline PD [9]. It has been esti-
mated that at least three-quarters of people with border-
line PD have had at least one suicide attempt, and the risk
of completed suicide amongst these patients may be as
high as 10 % [2]. Patients with borderline PD are also
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found to have earlier onset of suicidal behaviour than
those with depression only [2, 10]. Furthermore, individ-
uals with PD have a raised prevalence of alcohol use disor-
ders [11–13]. A study of over 40,000 individuals from the
US general population has found that 42 % of those with a
PD diagnosis had comorbid alcohol dependence com-
pared with 13 % of those without PD [13].
It has been reported that PD is associated with fre-
quent attendance to general practice and fewer referrals
to secondary care [14], which in the UK, includes spe-
cialist mental health inpatient and outpatient services.
Previous studies on suicidal behaviour amongst patients
with PD were, however, mostly conducted in secondary
care settings while surprisingly little is known about sui-
cide risk among people with PD who present to primary
care. Studies in the UK have also found that only 30 %
of people who died by suicide had contact with mental
health services in the preceding year [15], whereas 63 %
contacted their General Practitioner (GP) in the same
time period [16]. This suggests that GPs have a very im-
portant role in suicide prevention and better knowledge
of suicide risk amongst primary care patients diagnosed
with PD is needed.
In this study, we addressed the following research
questions: 1) Is PD among primary care patients linked
with a greater elevation in risk of suicide as compared to
patients with no history of mental illness and to patients
diagnosed with other psychiatric diagnoses? 2) Are these
relative risks modified by gender and age? 3) Are
patients with borderline PD at higher risk compared to
those with all other types of PD? (4) Does risk associated
with PD increase with comorbid alcohol misuse?
Methods
Data source: the Clinical Practice Research Datalink
(CPRD)
In the UK, over 98 % of the population are registered
with a general practice, with the clinical team providing
primary care and access to most other services from the
National Health Service (NHS) [17]. Even where the
patient leaves a family practice and joins another, their
GP record follows them, providing a continuous care
record. Our data source was the UK Clinical Practice
Research Datalink (CPRD), which is one of the largest
population-based, longitudinal, primary care databases
in the world (www.cprd.com). The CPRD has provided
anonymised primary care records for public health and
epidemiological research since 1987. It was initially
established in London as the Value Added Medical Prod-
ucts (VAMP) ‘research bank’, which expanded across the
UK to become the General Practice Research Database
(GPRD) in 1993, and was developed further as the
CPRD in 2012. It came into being because of a need to
develop good quality IT computer systems for general
practices in an era when most practices were still wholly
reliant on paper records. All practices in the CPRD use
Vision software rather than other general practice com-
puting systems, and have consented to share anonymous
data for academic research purposes. Around 7 % of the
UK population is now represented in the CPRD [17]. Al-
though practices were not selected according to any sci-
entific sampling strategy, a fortuitous by-product of the
largely ad hoc processes via which practices have contrib-
uted data to the Datalink is that it is broadly representa-
tive of the UK primary care patient population by basic
demographics such as age, gender and ethnicity [17].
All consultations for registered patients in participat-
ing practices are recorded in the CPRD, with compre-
hensive and detailed clinical coding - the ‘Read’ codes -
for symptoms, diagnoses, treatment (including pre-
scribed medication), and referral to other forms of NHS
care and to other health care providers. The September
2010 version of the CPRD we analysed contained ap-
proximately 10.6 million complete patient records. Be-
fore our study dataset was created, the Independent
Scientific Advisory Committee of the CPRD granted ap-
proval. Consent from individual patients is not required
to conduct CPRD-based studies.
To our knowledge there have been no published valid-
ation studies of personality disorder or alcohol misuse
diagnoses in the CPRD. However, two systematic reviews
have reported overall high levels of diagnostic validity in
the CPRD and good levels of agreement with other rou-
tinely collected data sources [18, 19]. A generic limita-
tion of the CPRD is that diagnostic behaviour varies
considerably between GPs and between general prac-
tices. Different doctors may apply varying clinical Read
codes for exactly the same condition, whilst some may
enter free-text information instead of clinical coding.
The Quality and Outcomes Framework was introduced
in 2004, and recent evidence indicates that this national
quality of care incentivisation initiative has produced a
marked improvement in diagnostic accuracy and com-
pleteness for some chronic conditions during recent
years in the CPRD [17].
The potential of this data source has been further en-
hanced by recent implementation of linkage to national
mortality records. In 2008, complete prospective and
historic linkage to national mortality registration data
was implemented via the Office for National Statistics
(ONS). Data linkage between CPRD and ONS is only
available for English practices that have consented to
participate in the linkage scheme. These linkages cover
approximately 75 % of the contributing CPRD practices
in England; the equivalent procedure has not yet been
implemented for CPRD practices in the other UK
nations: Scotland, Wales and Northern Ireland [17].
Therefore, our case-control study was nested within a
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subset of the whole CPRD. We included adult suicides if
the individual died between January 1st 2002 and De-
cember 31st 2011, and had at least a complete year of
“up-to-standard” CPRD clinical data prior to the individ-
ual’s index-date (death). This quality criterion was also
applied in selecting the matched living controls.
Suicide case definition
In the UK, most unnatural deaths of undetermined cause
(or ‘open verdicts’) among adults are considered likely to
be suicides [20]. To reduce false-negative misclassification,
and in line with standard practice for conducting epi-
demiological studies of suicide in the UK, our case defin-
ition included these open verdicts [21]. The following
ICD-10 codes were used: X60-84, Y10-Y34 (excluding
Y33.9; ie deaths with adjourned inquests that are mostly
deemed subsequently to be homicides), Y87.0 and Y87.2.
Identifying PD, other mental disorders and comorbid
alcohol misuse
To delineate diagnoses of PD we searched the textual
descriptions of the clinical Read codes for terms that in-
cluded: ‘personality’, ‘psychopath’ or ‘sociopath’. We ex-
amined the relevant Read codes descriptors and reached
a general consensus that we would define patients as
having a PD if they had a diagnosis that included a sub-
string of either ‘personality disorder’ or ‘psychopathic
disorder’ to ensure that we had a clinically relevant sam-
ple with a PD diagnosis. We then identified an additional
subgroup of ‘borderline PD: diagnosis of borderline or
unstable personality disorder’. The process used to
delineate diagnosis of the disorders was similar to that
described in Olier et al. [22].
We also constructed two additional medical definitions
to identify patients with: (1) Any diagnosed mental
health disorder: all Read codes beginning with the letter
‘E’, ie a diagnosis of ‘Mental Disorders’ (please note that
we excluded those patients coded for signs and symp-
toms of mental illness only but without an ‘E…’ diagnos-
tic code); (2) Comorbid alcohol misuse: all code
descriptions containing “alcohol” were extracted. Two
senior clinicians (co-author and consultant psychiatrist:
JS; first author and forensic mental health nurse consult-
ant: MD) then independently identified and agreed a list
of codes that indicated alcohol problems using a RAG
(Red/Amber/Green) agreement system, where Red was
defined as a definite clinically significant alcohol misuse
problem; Amber, possible problem and Green no prob-
lem. Independent ratings were reviewed and a consensus
on Red, definite clinically significant alcohol misuse, was
established. We opted not to investigate co-morbid PD
and illicit drug use due to suspected classification issues,
and because the number of suicide cases with such co-
morbidity was expected to be very small in the CPRD.
The diagnoses of PD, any mental health disorder and
the alcohol misuse definition are defined as ‘lifetime’ def-
initions in the sense that they are recorded at some
point in their CPRD GP clinical records [23]. The codes
contained in the Read ‘E’ category cover every type of
diagnosable mental illness across the full spectrum of
psychopathology, irrespective of levels of severity and
chronicity. In their meta-analysis of suicide risk in per-
sons with a mental disorder, Harris and Barraclough re-
ported that virtually all mental disorders, except for
intellectual disability and dementia, are associated with
an increased risk of suicide [24]. We therefore combined
all categories of mental illness other than personality
disorders and analysed them together as a single cat-
egory. In the UK, general practitioners typically diagnose
and treat less severe disorders such as depression, anx-
iety and stress, whereas more series conditions such as
psychotic disorders and PDs will be mostly treated by
psychiatrists in inpatient or outpatient facilities. The
great majority of persons with a diagnosed mental dis-
order in the study dataset were diagnosed with depres-
sion and/or anxiety disorders, and this applied to people
who died by suicide as well as the living control patients.
Mental illness diagnoses, whether made by a GP or by a
psychiatrist, are entered into the patient’s primary care clin-
ical record and are therefore recorded in the CPRD. The
Read code lists that we applied to delineate PD, borderline
PD, and clinically significant alcohol misuse, are available
online at: https://clinicalcodes.rss.mhs.man.ac.uk [23].
Study design and statistical analyses
The analyses were conducted using Stata v13 (Stata-
corps™). Due to the rarity of suicide we conducted a
large nested case-control study sampled from the whole
cohort at risk. The 2384 suicides in our case-control
study were matched to 46,899 living controls by gender,
age in years, and registered practice (median age for sui-
cide cases and living controls = 45; age range = 16–99).
Twenty controls from the same practice were selected
from the age and gender-specific risk set of each case to
maximise power for precise effect estimation [25]. We
calculated the prevalence of PD, other mental illnesses
and alcohol misuse disorder among cases and controls
separately and initially generated conditional logistic
regression models to estimate relative risks as exposure
odds ratios (ORs) for both genders combined. These
models were adjusted inherently for gender and age in
the matched design. We then fitted gender interaction
terms and formally tested their significance, and we esti-
mated gender age-specific effects. For some of the ana-
lyses we also formally compared two odds ratios against
each other (eg OR for PD vs. that for all other diagnosed
mental illnesses; OR for borderline PD vs. that for all PD
types combined).
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The incidence density sampling in the nested case-
control design meant that the odds ratios were interpret-
able as hazard ratios or incidence rate ratios, as would
be derived from survival analysis of the entire cohort
[26]. Although absolute risks and incidence rates cannot
be estimated from a case-control design due to the sam-
pling of living control subjects from the population at
risk, the relative risk between two groups (eg people
with diagnosis ‘x’ versus those without any mental
disorder diagnosis) can be inferred from the exposure
odds ratio value. Thus, in this hypothetical example, an
observed odds ratio value of 3.0 would indicate that sui-
cide risk was three times higher in people with diagnosis
‘x’ versus the remainder of the study population with no
mental illness.
Results
Relative risk among all patients
These estimates are presented in Table 1. Of the 2384
suicides, 110 (4.6 %) had a Read code diagnosis of PD
compared with 236 (0.5 %) of the 46,899 living controls.
The exposure odds ratio indicates an almost 20-fold
increased risk in these patients compared to those with
no mental illness diagnosis recorded in the CPRD. The
larger group of primary care patients with a different
type of mental illness diagnosis had a relative risk of sui-
cide of approximately 4.5. Direct comparison of the odds
ratios between the patients with PD and those with any
other mental illnesses showed that the risk was over four
times greater in the PD patients, and that this was a
highly significant excess risk versus other forms of
mental disorder (p < .001).
Relative risk stratified by gender and by age
Table 2 shows relative risk estimates stratified by gender.
Of the 110 suicides in total associated with PD, 75
(68.2 %) were males. A similar pattern of suicide risk
was seen in both genders, with an especially large eleva-
tion in risk observed among both male and female pa-
tients diagnosed with PD. Male patients diagnosed with
PD were almost 16 times more likely to die by suicide
compared to patients with no mental illness, and in
female patients with PD, the equivalent relative risk
estimate was 38. We fitted a gender interaction term,
which indicated that this large difference in effect size
was statistically significant (p = .005). In both genders
there was also a large and significant (p < .001) excess
risk in PD patients compared to people with other men-
tal illnesses, with the excess being 7.2 times for females
compared with 3.7 times for males.
Similar to the gender-specific analyses described
above, we then stratified the relative risk estimates into
the following five age groups: 16–29, 30–39, 40–49, 50–
59, 60 years and over. The youngest age band was se-
lected to reflect young adulthood, as reported recently
by the World Health Organizaton (WHO) in a suicide
prevention report [27]. We then examined equal 10-year
bands until 60 years and older. It was not possible to
examine older age adults separately according to the
65 years and over as defined by the WHO, due to the
small number of suicide cases diagnosed with PD in the
case-control study sample. These results are given in
Table 3. The effect sizes were significantly heterogeneous
across the age strata (p = .01), with the greatest eleva-
tions in risk compared with those with no mental disor-
ders being seen among the two youngest age groups
(relative risks of 33 and 26, respectively). In the 60 years
and older age group, the almost ten-fold increase in risk
was still large and significant, but in relative terms it was
a smaller elevation in risk than was observed at younger
age. Again, substantial and significant (p < .001) excess
risks compared to patients with other mental illnesses
were seen across all age bands of patients with PD, with
the smallest excess risk found in the older age patients.
Borderline PD versus all other types of PD
We examined relative risk of suicide in the small sub-
group of patients diagnosed with borderline PD (Table 4).
In these patients we observed a relative risk of 37 com-
pared to patients with no mental illness, and a border-
line significant doubled risk (p = .05) compared with all
of the other patients diagnosed with PD.
Alcohol misuse as an effect modifier
These results, which are presented in Table 5, indicate
that a clinically significant level of comorbid alcohol
Table 1 Odds ratios for suicide in patients with a personality disorder (PD) vs. no mental illness and vs. other mental illnesses
Exposure categories Suicide cases Living controls
n % n % Odds ratioa (95 % CI)
No mental illness 887 37.2 33,636 71.7 1.00 (Ref.)
Other mental illness (not PD) 1387 58.2 13,027 27.8 4.47 (4.08–4.89)
Personality disorder (PD) 110 4.6 236 0.5 19.79 (15.55–25.18)
Total 2384 100 46,899 100
PD vs. other mental illness - - - - 4.43 (3.50–5.61)
aOdds ratio estimated by conditional logistic regression, adjusted inherently for age and gender in the matched design
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misuse exacerbated the already heightened risk of sui-
cide among patients diagnosed with PD. Thus, compared
to patients with no mental illness or alcohol misuse
diagnoses, the relative risk linked to PD alone was 16.5,
whereas a markedly greater relative risk of 45 was ob-
served in those patients diagnosed with PD and also
with alcohol misuse. This excess risk in the latter sub-
group of patients was statistically significant (p = .001).
Discussion
Summary of findings
Among primary care patients in CPRD, we found a 20-
fold increase in risk of suicide in those diagnosed with
PD compared to those with no mental disorder, and an
over four-fold increase in risk when compared with pa-
tients with other mental disorder diagnoses. Females
with PD had a significantly greater elevation in suicide
risk than male patients with PD, compared to their gen-
der and age-matched peers without any mental illness
diagnoses. Significant risks associated with PD diagnosis
were identified across all age ranges, although the great-
est elevations were in the younger age ranges, 16–39
years. A diagnosis of borderline PD doubled the risk of
suicide when compared to patients diagnosed with other
types of PD. Clinically significant comorbid alcohol mis-
use significantly increased the risk of suicide in those
with a diagnosis of PD.
Comparison with previous literature
To our knowledge this is the first epidemiological study
to examine suicide risk in a representative primary care
sample of UK patients with PD, making it difficult to
compare with other studies. However, our main findings
are generally in line with published findings, except for
the much larger effect sizes we found. For example,
Schneider et al. [5] reported that PD was associated with
a seven-fold increase in suicide risk compared with those
in the general population with no mental illnesses [5].
Risks were particularly raised amongst those with a diag-
nosis of Cluster B personality disorders (which includes
borderline type), with an odds ratio of 7.5 compared
with 4.5 for Cluster A and 4.1 for Cluster C. In our
study, a diagnosis of PD was associated with a 20-fold el-
evated risk compared with those with no mental disor-
ders while borderline PD was linked with double the risk
versus other types of PD. Schneider et al. [5] also found
that being diagnosed with comorbid PD and alcohol use
disorders elevated the risk 15-fold compared with those
with no psychiatric diagnosis, while we found a 45-fold
increase. This finding is particularly alarming, suggesting
that comorbid PD and alcohol misuse represents a po-
tent determinant of elevated suicide risk in community
settings.
In a national Danish cohort study of psychiatric inpa-
tients, Hiroeh et al. [7] reported that PD was associated
with a 16-fold increase in suicide risk in women (stan-
dardised mortality ratio, SMR = 1568) and 12-fold in
men (SMR = 1198) compared with people who had not
been admitted for psychiatric treatment [7]. Similar pat-
terns were found in our primary care-based study, al-
though the effect sizes were larger still (ORs = 38 for
women and 16 for men). The greater relative risk found
for women may be strongly linked with the high self-
harm rate in women with PD [28].
Strengths and limitations
The CPRD uniquely provided a large, detailed, and na-
tionally representative computerised cohort of primary
care-treated patients, including those with mental illness
and comorbid alcohol misuse, with complete linkage
Table 2 Gender-specific odds ratios for suicide
Exposure categories Suicide cases Living controls
n % n % Odds ratioa (95 % CI)
Men:
No mental illness 731 40.5 26,160 74.0 1.00 (Ref.)
Other mental illness (not PD) 998 55.3 9025 25.5 4.28 (3.87–4.74)
Personality disorder (PD) 75 4.2 184 0.5 15.96 (12.02–21.19)
Total 1804 35,369
PD vs. other mental illness - - - - 3.73 (2.82–4.93)
Women:
No mental illness 156 26.9 7476 64.8 1.00 (Ref.)
Other mental illness (not PD) 389 67.1 4002 34.7 5.27 (4.32–6.42)
Personality disorder (PD) 35 6.0 52 0.5 38.16 (23.85–61.06)
Total 580 100 11,530
PD vs. other mental illness - - - - 7.24 (4.63–11.34)
aOdds ratio estimated by conditional logistic regression, adjusted inherently for age and gender in the matched design
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Table 3 Age-stratified odds ratios for suicide
Exposure categories Suicide cases Living controls
n % n % Odds ratioa (95 % CI)
16–29 years:
No mental illness 186 51.0 5675 79.3 1.00 (Ref.)
Other mental illness (not PD) 162 44.4 1459 20.4 3.58 (2.86–4.49)
Personality disorder (PD) 17 4.7 19 0.3 32.57 (16.03–66.20)
Total 365 100 7153 100
PD vs. other mental illness - - - - 9.09 (4.47–18.50)
30–39 years:
No mental illness 182 33.8 7812 73.8 1.00 (Ref.)
Other mental illness (not PD) 329 61.2 2715 25.7 5.81 (4.79–7.05)
Personality disorder (PD) 27 5.0 52 0.5 25.98 (15.73–42.91)
Total 538 100 10,579 100
PD vs. other mental illness - - - - 4.47 (2.75–7.29)
40–49 years:
No mental illness 196 35.7 7727 71.6 1.00 (Ref.)
Other mental illness (not PD) 317 57.7 2996 27.8 4.61 (3.81–5.58)
Personality disorder (PD) 36 6.6 66 0.6 23.43 (15.13–36.28)
Total 549 100 10,789 100
PD vs. other mental illness - - - - 5.08 (3.32–7.78)
50–59 years:
No mental illness 125 30.0 5529 67.2 1.00 (Ref.)
Other mental illness (not PD) 274 65.7 2643 32.1 5.06 (4.04–6.34)
Personality disorder (PD) 18 4.3 52 0.6 16.81 (9.45–29.89)
Total 417 100 8224 100
PD vs. other mental illness - - - - 3.32 (1.90–5.81)
60 years and over:
No mental illness 198 38.5 6893 67.9 1.00 (Ref.)
Other mental illness (not PD) 305 59.2 3214 31.7 3.52 (2.91–4.25)
Personality disorder (PD) 12 2.3 47 0.5 9.46 (4.92–18.20)
Total 515 100 10,154 100
PD vs. other mental illness - - - - 2.69 (1.41–5.15)
aOdds ratio estimated by conditional logistic regression, adjusted inherently for age and gender in the matched design
Table 4 Odds ratios for suicide specific to patients with borderline personality disorder (BPD)
Exposure categories Suicide cases Living controls
n % n % Odds ratioa (95 % CI)
No mental illness 887 37.2 33,636 71.7 1.00 (Ref.)
Mental illness (not PD or BPD) 1387 58.2 10,027 27.8 4.47 (4.08–4.89)
Other PD (not BPD) 94 3.9 217 0.5 18.30 (14.17–23.64)
Borderline PD 16 0.7 19 0.04 37.28 (19.00–73.13)
Total b 2384 100 46,899 100
BPD vs. other PD - - - - 2.04 (1.00–4.15)
aOdds ratio estimated by conditional logistic regression, adjusted inherently for age and gender in the matched design
bTo avoid repetition with Table 1 we have not reported the ‘Mental illness: not PD’ in this table
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and follow-up of cause-specific mortality. Using a nested
case-control design to capture all cases in the cohort at
risk, and with random sampling of living matched con-
trols from the cohort, examining risk factors for rare ad-
verse events like suicide was possible. Biases that
commonly flaw epidemiological studies can also be
minimised. For example, information bias was precluded
because the data were collected prospectively without
knowledge of the subsequent outcome. Selection into
primary care was an unlikely source of major bias be-
cause almost all UK residents are registered with a GP
soon after they are born, and when people move address
and register with a new practice their complete primary
health care record is transferred automatically. Thus, the
CPRD yields a representative community-based epi-
demiological sample.
The major limitation of our study was the potential for
incomplete ascertainment in the CPRD of all patients di-
agnosed with PD, all other types of mental illness, and
comorbid alcohol misuse. This is a widely recognised
issue for all CPRD-based studies [17]. A second limita-
tion concerns diagnostic validity and reliability in the
Read codes that were recorded in the CPRD. All infor-
mation recorded in the Datalink can be linked to a
health professional within the general practice, but the
link does not necessarily reflect the true diagnostic path,
especially regarding information from secondary care
(for example, hospital letters inputted by administrative
staff ). However, our study benefited from the lead au-
thor (MD) and two of the co-authors (JS and LA) having
extensive clinical experience in the assessment and man-
agement of PD, thus minimising the risk of misclassifica-
tion. Although we did not know how or by whom PD
was diagnosed, we applied a stringent set of diagnostic
codes to identify people with PD to ensure we had a
clinically relevant sample. For PD to be recorded in pri-
mary care notes, it may have been diagnosed in specialist
care - it is not a diagnosis commonly made by GPs and
attributed to patients; thus, symptoms may be severe.
Therefore, the high risk identified in the study reflects
clinically evident PD rather than all patients with PD
traits. Identification of ‘cases’ of clinically significant
alcohol misuse was also challenging, because it is not
consistently and systematically recorded in the CPRD.
However, as described in the Methods section, we used
a robust approach to identify alcohol misuse deemed to
be at a clinically significant level. Misclassification that
occurs when using the CPRD for epidemiological
purposes may have attenuated the observed odds ratios
conservatively towards unity because they were distrib-
uted non-differentially between suicide cases and con-
trols [29]. A third important limitation was that we
could not estimate incidence rates or absolute risk of
suicide from the nested case-control design. This is true
of all case-control studies, although the ‘nested’ variant
with random sampling of controls from the cohort at
risk is a robust statistically efficient design for examining
rare adverse events such as suicide. Two final limitations
of this CPRD-based study include inability to stratify PD
and other mental disorders according to their degree of
severity, and to examine suicide risk in patients with
more than one diagnosed PD.
Interpretation of the findings and their implications
The findings from this study highlight the importance of
considering age, gender and concurrent alcohol misuse
when assessing suicide risk among primary care patients
diagnosed with PD. With increasing age, certain risky
behaviours associated with PD and suicide, such as im-
pulsivity and aggression, may become less common,
contributing to the lower elevated suicide risks amongst
those from the older age groups [30]. However, comor-
bid psychiatric disorders may enhance the expression of
other dysfunctional traits such as dementia and social
withdrawal in older people making it more complex to
diagnose PD in this group [30, 31]. The diagnostic
criteria for PD and in particular borderline PD - includ-
ing repeated non-fatal self-harm, impulsivity, affective
instability, and mood disorder - have consistently been
found to be strongly linked to suicidal behaviour [2, 4,
32, 33]. Self-harming behaviour among people with a
diagnosis of PD, but especially borderline PD, tends to
be ambivalent in intent where emotional instability and
impulsivity are very common. This is complicated further
Table 5 Odds ratios for suicide in patients with a personality disorder (PD) with and without a co-morbid alcohol misuse disorder
Exposure categories Suicide cases Living controls
n % n % Odds ratioa (95 % CI)
No mental illness or alcohol misuse 884 37.0 33,613 71.7 1.00 (Ref.)
Mental illness (not PD or alcohol) 1234 51.8 12,494 26.6 4.15 (3.79–4.56)
Personality disorder (PD) only 80 3.4 208 0.4 16.52 (12.59–21.68)
Alcohol misuse only 156 6.5 552 1.2 12.18 (10.03–14.80)
PD + alcohol misuse 30 1.3 28 0.06 45.40 (26.84–76.78)
Total 2384 100 46,899 100
aOdds ratio estimated by conditional logistic regression, adjusted inherently for age and gender in the matched design
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as often the level of intent of self-harm can fluctuate rap-
idly and trying to accurately predict a rare event such as
suicide is seldom possible. Therefore, enhancing the skills
of GPs, through training opportunities, to identify and as-
sess PD and personality traits factors could help in redu-
cing the risk of suicide; this would need to take account of
the high false positive rate amongst those who repeatedly
self-harm. A standardised assessment tools such as the
Standardised Assessment of Personality [34] may be help-
ful as a first-stage screen as part of a two-stage procedure
for case identification [35], which could be used regardless
of the age or gender of patients and could be integrated
into a primary care consultation.
Similar to mental health services, it is possible that the
elevated risk of suicide in primary care is related to a
paucity of effective interventions to manage the risk.
There is a lack of consensus about the extent to which
people with PD are amenable to therapeutic interven-
tions [36] and primary health care staff may view people
with PD as ‘untreatable’. A sense of futility combined
with a lack of therapeutic skills could be exacerbating an
already elevated risk among these patients. Closely
linked to perceived ‘untreatabilty’ is the tendency for pa-
tients with PD to be viewed negatively by treating psy-
chiatrists and other clinicians due to their antisocial,
disruptive and treatment resistant symptoms [37], espe-
cially if they self-harm [38]. There is also some evidence
that those with a diagnosis of PD are less likely than
those without to be referred by GPs to specialist psychi-
atric services [14] and GPs have been shown to view
those with a PD as ‘less compliant’, ‘less likeable’ and
‘more stressful’ to deal with [14]. This may be further
exacerbated by time-limited consultations.
Nevertheless, GPs remain in a unique position to as-
sess the risk of suicide in people with PD and to inter-
vene. This would mean working with specialist care,
agreed clinical pathways and availability of services for
comorbidities such as alcohol misuse, as well as oppor-
tunities for GPs to develop specific clinical skills. Pres-
ence of PD traits, alcohol misuse and suicidal behaviour
and frequent attendance at clinic could be the basis for a
‘flag’ alert in primary care records for treatment and/or
referral [16]. Given that a diagnosis of alcohol use disor-
ders is associated with a much heightened risk of suicide
in patients with PD, detection and treatment for alcohol
misuse should be a priority [39]. In addition, since im-
pulsivity is a trait that is common among people diag-
nosed with PD, substance use and suicidal behaviour
[32, 40] treatments should also target difficulties in
impulse control.
Given the strong link found in this study between PD
and suicide in primary care, and the paucity of robust
evidence in this setting, there is a clear need for further
research. Attempts should be made to try and replicate
the findings from this study in different primary care
samples from other countries. From a clinical perspec-
tive, the way that GPs assess, support and manage
people with PD should be further explored, both quanti-
tatively and qualitatively. A review of the links between
primary and specialist mental health services would be
useful to establish the mutual expectations of the refer-
rer and referee and to evaluate treatment options
available [41]. The role of specialist mental health
services and the interface with primary care services in
managing the needs and risks among people with PD
also requires evaluation.
Conclusions
In a large representative sample of UK primary care
patients, we found elevated risk of suicide amongst those
with PD versus those with no recorded mental disorder
or other psychiatric illnesses. The risks were particularly
raised amongst those with comorbid alcohol misuse dis-
order or borderline PD. GPs have a potentially key role
to play in reducing risk of suicidal behaviour by inter-
vening with patients diagnosed with PD, particularly
when comorbid alcohol misuse is present.
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